FI68220C - Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid Download PDF

Info

Publication number
FI68220C
FI68220C FI793041A FI793041A FI68220C FI 68220 C FI68220 C FI 68220C FI 793041 A FI793041 A FI 793041A FI 793041 A FI793041 A FI 793041A FI 68220 C FI68220 C FI 68220C
Authority
FI
Finland
Prior art keywords
methyl
pyrrolidinylmethyl
dimethoxy
methylsulfamoylbenzamide
acid
Prior art date
Application number
FI793041A
Other languages
English (en)
Finnish (fi)
Other versions
FI68220B (fi
FI793041A (fi
Inventor
Michel Thominet
Jacques Perrot
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of FI793041A publication Critical patent/FI793041A/fi
Application granted granted Critical
Publication of FI68220B publication Critical patent/FI68220B/fi
Publication of FI68220C publication Critical patent/FI68220C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI793041A 1978-10-11 1979-10-01 Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid FI68220C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7829005A FR2438650A1 (fr) 1978-10-11 1978-10-11 N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
FR7829005 1978-10-11

Publications (3)

Publication Number Publication Date
FI793041A FI793041A (fi) 1980-04-12
FI68220B FI68220B (fi) 1985-04-30
FI68220C true FI68220C (fi) 1985-08-12

Family

ID=9213607

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793041A FI68220C (fi) 1978-10-11 1979-10-01 Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid

Country Status (44)

Country Link
US (1) US4364867A (fr)
JP (1) JPS5553268A (fr)
AR (1) AR223186A1 (fr)
AT (1) AT376203B (fr)
AU (1) AU528827B2 (fr)
BE (1) BE879139A (fr)
BG (1) BG30926A3 (fr)
CA (1) CA1133913A (fr)
CH (1) CH641775A5 (fr)
CS (1) CS221527B2 (fr)
CY (1) CY1203A (fr)
DD (1) DD146459A5 (fr)
DE (1) DE2939914C2 (fr)
DK (1) DK146157C (fr)
EG (1) EG14181A (fr)
ES (1) ES8102093A1 (fr)
FI (1) FI68220C (fr)
FR (1) FR2438650A1 (fr)
GB (1) GB2033900B (fr)
GR (1) GR65219B (fr)
HK (1) HK12384A (fr)
HU (1) HU178113B (fr)
IE (1) IE48957B1 (fr)
IL (1) IL58379A (fr)
IN (1) IN151482B (fr)
IT (1) IT1162680B (fr)
JO (1) JO1041B1 (fr)
LU (1) LU81745A1 (fr)
MA (1) MA18603A1 (fr)
MC (1) MC1288A1 (fr)
MX (1) MX6194E (fr)
NL (1) NL7907307A (fr)
NO (1) NO152971C (fr)
NZ (1) NZ191699A (fr)
OA (1) OA06351A (fr)
PH (1) PH15431A (fr)
PL (1) PL125527B1 (fr)
PT (1) PT70277A (fr)
RO (1) RO78157A (fr)
SE (1) SE434835B (fr)
SU (1) SU946401A3 (fr)
YU (1) YU43460B (fr)
ZA (1) ZA795375B (fr)
ZM (1) ZM8179A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US6197309B1 (en) 1998-08-03 2001-03-06 Ronald E. Wheeler Prostate formula

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (fr) * 1966-01-21 1968-05-06
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
CH605793A5 (fr) * 1974-03-05 1978-10-13 Ile De France
US4158060A (en) * 1974-12-18 1979-06-12 Synthelabo 2-Methoxy-benzamide derivatives
FR2358892A1 (fr) * 1976-07-19 1978-02-17 Ile De France N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Also Published As

Publication number Publication date
MA18603A1 (fr) 1980-07-01
DK146157B (da) 1983-07-11
SU946401A3 (ru) 1982-07-23
AT376203B (de) 1984-10-25
CY1203A (en) 1983-12-31
YU232279A (en) 1983-02-28
IE791903L (en) 1980-04-11
GR65219B (en) 1980-07-30
SE434835B (sv) 1984-08-20
OA06351A (fr) 1981-06-30
SE7908227L (sv) 1980-04-12
AU5151979A (en) 1980-04-17
PL125527B1 (en) 1983-05-31
NL7907307A (nl) 1980-04-15
AR223186A1 (es) 1981-07-31
NO152971C (no) 1985-12-27
DD146459A5 (de) 1981-02-11
DE2939914A1 (de) 1980-04-30
IL58379A0 (en) 1980-01-31
ZA795375B (en) 1980-10-29
BG30926A3 (en) 1981-09-15
NO793240L (no) 1980-04-14
NO152971B (no) 1985-09-16
EG14181A (en) 1984-09-30
LU81745A1 (fr) 1980-05-07
FR2438650A1 (fr) 1980-05-09
AU528827B2 (en) 1983-05-12
CH641775A5 (fr) 1984-03-15
CS221527B2 (en) 1983-04-29
PT70277A (fr) 1979-11-01
MX6194E (es) 1984-12-13
FR2438650B1 (fr) 1981-08-14
IT7950444A0 (it) 1979-10-03
DK146157C (da) 1983-12-05
JPS641470B2 (fr) 1989-01-11
CA1133913A (fr) 1982-10-19
FI68220B (fi) 1985-04-30
ES484814A0 (es) 1980-12-16
IT1162680B (it) 1987-04-01
DK422879A (da) 1980-04-12
BE879139A (fr) 1980-04-02
FI793041A (fi) 1980-04-12
ZM8179A1 (en) 1980-07-21
ATA639179A (de) 1984-03-15
PH15431A (en) 1983-01-18
HK12384A (en) 1984-02-24
JO1041B1 (en) 1982-07-10
US4364867A (en) 1982-12-21
MC1288A1 (fr) 1980-07-22
ES8102093A1 (es) 1980-12-16
IE48957B1 (en) 1985-06-26
GB2033900B (en) 1982-09-15
IL58379A (en) 1983-03-31
IN151482B (fr) 1983-04-30
RO78157A (fr) 1982-02-01
GB2033900A (en) 1980-05-29
JPS5553268A (en) 1980-04-18
PL218673A1 (fr) 1980-07-28
DE2939914C2 (de) 1986-05-22
HU178113B (en) 1982-03-28
YU43460B (en) 1989-08-31
NZ191699A (en) 1981-11-19

Similar Documents

Publication Publication Date Title
JP2001507676A (ja) 抗血栓性有機硝酸塩
IE47798B1 (en) Substituted ortho-anisamides,methods of preparing them,compositions containing them and their application as psychotropic agents
US4361703A (en) Para-amino(or nitro)phenyl N-acetylaminothioalkanoates
US4038416A (en) Pharmaceutical composition and method of the use thereof
HU193348B (en) Process for producing piroxicam salts of antiflogistic activity
EP0682947B1 (fr) Médicament pour le traitement thérapeutique prophylactique des maladies causées par une hyperplasie des cellules musculaires lisses
FI68220B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid
NZ228894A (en) 4-quinoline carboxylic acid-containing pharmaceutical compositions
FI73970C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 2-amino-3-(halobensoyl)-metyl-fenylaettiksyra och estrar och salter daerav.
EP2692724B1 (fr) Dérivé chiral de 3-hydroxypyrid-4-one et synthèse et utilisation de celui-ci
US4263316A (en) N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives, methods of preparing them and their application to the treatment of troubles of the lower part of the body
NZ195061A (en) 2-amino-3-benzoyl-phenylacetamides;anti-inflammatory and analgesic compositions
RU2294198C2 (ru) Производные арил(или гетероарил)азолилкарбинола для лечения респираторных заболеваний
US3577551A (en) Methods for treating pain,inflammation and cough
CA1053663A (fr) Methode de preparation de composes anti-inflammatoires, antirhumatismaux
US5972940A (en) Arginine analogues having nitric oxide synthase inhibitor activity
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
SK695188A3 (en) Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n-(2- -pyridyl)-2h-thieno (2,3-e)-1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
CN113214275B (zh) 吡喃并咔唑生物碱类衍生物及其治疗神经系统疾病的用途
US4472424A (en) Esters of 2-thenoylmercaptopropionylglycine with substituted hydroxybenzenes, process for their preparation and pharmaceutical compositions containing same
KR830001211B1 (ko) N-(1-메틸-2-피롤리디닐-메틸)-2,3-디메톡시-5-메틸설파모일 벤즈아미드의 제조방법
SU1001855A3 (ru) Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей
EP0045473A1 (fr) Composition pharmaceutique contenant comme principe actif un dérivé du benzofuranne carboxamide
NZ199008A (en) 2,3,3a,4,5,6-hexahydro-ih-indolo(3,2,1-de)(1,5)-naphthyridines
KR820001020B1 (ko) 4-아미노 5-알킬설포닐 오르토-아니스 아미드 유도체의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SOCIETE D'ETUDES SCIENTIFIQUES ET